BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25511292)

  • 1. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
    Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
    Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
    Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
    Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies.
    Song J; Kai M; Zhang W; Zhang J; Liu L; Zhang B; Liu X; Wang R
    Peptides; 2011 Sep; 32(9):1934-41. PubMed ID: 21827806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
    Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
    J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways.
    Säälik P; Padari K; Niinep A; Lorents A; Hansen M; Jokitalo E; Langel U; Pooga M
    Bioconjug Chem; 2009 May; 20(5):877-87. PubMed ID: 19348413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transportan 10 improves the anticancer activity of cisplatin.
    Izabela R; Jarosław R; Magdalena A; Piotr R; Ivan K
    Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):485-97. PubMed ID: 26899863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
    Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
    Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo.
    Bárány-Wallje E; Gaur J; Lundberg P; Langel U; Gräslund A
    FEBS Lett; 2007 May; 581(13):2389-93. PubMed ID: 17485081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
    Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
    Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
    Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
    Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
    Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
    Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular uptake of cell-penetrating peptides pVEC and transportan in plants.
    Chugh A; Eudes F
    J Pept Sci; 2008 Apr; 14(4):477-81. PubMed ID: 17985395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cargo delivery kinetics of cell-penetrating peptides.
    Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
    Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
    Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
    J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
    Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes.
    Arsov Z; Nemec M; Schara M; Johansson H; Langel U; Zorko M
    J Pept Sci; 2008 Dec; 14(12):1303-8. PubMed ID: 18683276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.